Sublingual allergen immunotherapy in immunosuppressed rheumatoid arthritis patients: Safety and clinical outcomes.

Kobayashi Y, Nakagomi D, Hanai S, Tran NQV, Nakamura Y, Matsuoka T, Sakurai D, Nakao A

Open source

DOI
10.1016/j.jacig.2026.100728
Published
2026 Jul
Container
The journal of allergy and clinical immunology. Global
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacig.2026.100728,
  title = {Sublingual allergen immunotherapy in immunosuppressed rheumatoid arthritis patients: Safety and clinical outcomes.},
  author = {Kobayashi Y and Nakagomi D and Hanai S and Tran NQV and Nakamura Y and Matsuoka T and Sakurai D and Nakao A},
  year = {2026},
  journal = {The journal of allergy and clinical immunology. Global},
  doi = {10.1016/j.jacig.2026.100728},
  url = {https://doi.org/10.1016/j.jacig.2026.100728}
}

RIS

TY  - JOUR
TI  - Sublingual allergen immunotherapy in immunosuppressed rheumatoid arthritis patients: Safety and clinical outcomes.
AU  - Kobayashi Y
AU  - Nakagomi D
AU  - Hanai S
AU  - Tran NQV
AU  - Nakamura Y
AU  - Matsuoka T
AU  - Sakurai D
AU  - Nakao A
PY  - 2026
JO  - The journal of allergy and clinical immunology. Global
DO  - 10.1016/j.jacig.2026.100728
UR  - https://doi.org/10.1016/j.jacig.2026.100728
ER  - 

APA

Y, K., D, N., S, H., NQV, T., Y, N., T, M., D, S., & A, N. (2026). Sublingual allergen immunotherapy in immunosuppressed rheumatoid arthritis patients: Safety and clinical outcomes.. The journal of allergy and clinical immunology. Global. https://doi.org/10.1016/j.jacig.2026.100728

Source records